Changes in mortality associated with different hematologic malignancies during the pandemic in the United States
Description
Patients with hematologic malignancies are at increased risk of adverse COVID-19 outcomes; nonetheless, only sparse population-based data are available on mortality related to hematologic cancers during the pandemic. Number of deaths and age
